Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Fanapt. Always confirm against the full prescribing information.
100 interactions
Abatacept
The metabolism of Iloperidone can be increased when combined with Abatacept.
Level 1 evidence
Abiraterone
The metabolism of Iloperidone can be decreased when combined with Abiraterone.
Level 1 evidence
Acalabrutinib
The metabolism of Iloperidone can be decreased when combined with Acalabrutinib.
Level 1 evidence
Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Iloperidone.
Level 2 evidence
Acebutolol
Acebutolol may increase the orthostatic hypotensive activities of Iloperidone.
Level 2 evidence
Acetaminophen
The metabolism of Iloperidone can be decreased when combined with Acetaminophen.
Level 1 evidence
Acetazolamide
The metabolism of Iloperidone can be decreased when combined with Acetazolamide.
Level 1 evidence
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Iloperidone.
Level 2 evidence
Adagrasib
The metabolism of Iloperidone can be decreased when combined with Adagrasib.
Level 1 evidence
Adalimumab
The metabolism of Iloperidone can be increased when combined with Adalimumab.
Level 1 evidence
Albuterol
The therapeutic efficacy of Salbutamol can be decreased when used in combination with Iloperidone.
Level 2 evidence
Aldesleukin
The metabolism of Iloperidone can be decreased when combined with Aldesleukin.
Level 1 evidence
Enter your NPI to unlock 19 major interactions for Fanapt
Fanapt (Iloperidone) has 844 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Fanapt (Iloperidone) has 145 major, 545 moderate, and 154 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Fanapt. Always confirm against the full prescribing information.